FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nicolas Paquot

Research Profile

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
J De Flines; N Esser; Françoise Luyckx; Nicolas Paquot; M Rorive; André J Scheen
[Clinical evaluation of an obese person].
M Franck; Nicolas Paquot; André J Scheen
[Influence of body weight on the natural history of and the therapeutic approaches to type 1 diabetes].
J De Flines; A De Roover; M Franck; Nicolas Paquot; M Rorive; André J Scheen
[Metabolic surgery: an increasing place in the management of diabetes].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nicolas Paquot (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: J De Flines; N Esser; Françoise Luyckx; Nicolas Paquot; M Rorive; André J Scheen
[Clinical evaluation of an obese person].
Revue médicale de Liège 2013;68(3):148-53.
2012: M Franck; Nicolas Paquot; André J Scheen
[Influence of body weight on the natural history of and the therapeutic approaches to type 1 diabetes].
Revue médicale de Liège 2012;67(9):461-7.
2012: J De Flines; A De Roover; M Franck; Nicolas Paquot; M Rorive; André J Scheen
[Metabolic surgery: an increasing place in the management of diabetes].
Revue médicale suisse 2012;8(351):1621-4, 1626-7.
2012: Nicolas Paquot; J De Flines; M Rorive
[Obesity: a model of complex interactions between genetics and environment].
Revue médicale de Liège 2012;67(5-6):332-6.
2012: André J Scheen; Nicolas Paquot
[Type 2 diabetes: journey in the heart of a complex disease].
Revue médicale de Liège 2012;67(5-6):326-31.
2012: Nicolas Paquot; André J Scheen
[Which HbA1c and lipid targets in patients with type 2 diabetes?].
Revue médicale de Liège 2012;67(2):98-103.
2011: N Esser; Nicolas Paquot; André J Scheen
[Type 2 diabetes and anti-inflammatory agents: new therapeutic prospects?].
Revue médicale suisse 2011;7(306):1614-8, 1620.
2011: Nicolas Paquot
[Diagnosis of non intentional weight loss in adults].
Revue médicale de Liège 2011;66(7-8):456-60.
2011: André J Scheen; Nicolas Paquot
[Therapeutic approaches to improve blood glucose control in a patient with type 2 diabetes on a metformin-sulfonylurea combination].
Revue médicale de Liège 2011;66(4):215-21.
2011: André J Scheen; J De Flines; M Rorive; Arnaud De Roover; Nicolas Paquot
[Metabolic surgery: an evolution (or revolution) of bariatric surgery?].
Revue médicale de Liège 2011;66(4):183-90.
2011: André J Scheen; Nicolas Paquot
[Clinical vignette. Which combination of oral glucose-lowering agents to use after failure of metformin monotherapy in type 2 diabetes?].
Revue médicale de Liège 2011;66(3):170-5.
2010: Luc Tappy; Kim-Anne Lê; Christel Tran; Nicolas Paquot
Fructose and metabolic diseases: new findings, new questions.
Nutrition (Burbank, Los Angeles County, Calif.) 2010;26(11-12):1044-9.
2010: Alessandra Iovino; Nicolas Paquot; André J Scheen
[Reduction of obesity-related metabolic risk by modulating tissue exposition to cortisol].
Revue médicale suisse 2010;6(260):1608-12.
2010: André J Scheen; Nicolas Paquot
[Multirisk approach of the type 2 diabetic patient: controversies surrounding target values after the ACCORD trial].
Revue médicale suisse 2010;6(260):1582-7.
2010: Nicolas Paquot
[Deleterious effects of lack of compliance to lifestyle and medication in diabetic patients].
Revue médicale de Liège 2010;65(5-6):326-31.
2010: N Esser; Nicolas Paquot; André J Scheen
[Fitness versus fatness: respective cardiometabolic impacts at different age ranges].
Revue médicale de Liège 2010;65(4):199-205.
2009: André J Scheen; J De Flines; A De Roover; Nicolas Paquot
Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives.
Diabetes & metabolism 2009;35(6 Pt 2):537-43.
2009: M Rorive; J De Flines; Nicolas Paquot; André J Scheen
[Management of an obese person with metabolic syndrome].
Revue médicale de Liège 2009;64(12):651-6.
2009: E Beck; N Esser; Nicolas Paquot; André J Scheen
[Metabolically obese normal-weight individuals and metabolically healthy, but obese, subjects].
Revue médicale suisse 2009;5(214):1644-6, 1648-9.
2009: Pierre Delanaye; Etienne Cavalier; Régis P Radermecker; Nicolas Paquot; Gisèle Depas; Jean-Paul Chapelle; André J Scheen; Jean-Marie Krzesinski
Estimation of GFR by different creatinine- and cystatin-C-based equations in anorexia nervosa.
Clinical nephrology 2009;71(5):482-91.
2009: André J Scheen; Nicolas Paquot
[Vildagliptin (Galvus) and fixed combination vildagliptine-metformin (Eucreas) in the treatment of type 2 diabetes].
Revue médicale de Liège 2009;64(3):161-7.
2009: André J Scheen; Nicolas Paquot
Use of cannabinoid CB1 receptor antagonists for the treatment of metabolic disorders.
Best practice & research. Clinical endocrinology & metabolism 2009;23(1):103-16.
2008: André J Scheen; Nicolas Paquot; Pierre J Lefebvre
[United Kingdom Prospective Diabetes Study (UKPDS): 10 years later].
Revue médicale de Liège 2008;63(10):624-9.
2008: André J Scheen; Nicolas Paquot; Luc F Van Gaal
[CB1 receptor inhibition and glucose metabolism: role of rimonabant in type 2 diabetes].
Revue médicale suisse 2008;4(168):1812-7.
2008: André J Scheen; Nicolas Paquot
Inhibitors of cannabinoid receptors and glucose metabolism.
Current opinion in clinical nutrition and metabolic care 2008;11(4):505-11.
2008: R R Radermecker; JC Philips; BJ Jandrain; Nicolas Paquot; Pierre J Lefèbvre; André J Scheen
[Brain, a gluco-dependent organ: toxic effects of hypoglycaemia and hyperglycaemia].
Revue médicale de Liège 2008;63(5-6):280-6.
2008: Pierre Delanaye; Etienne Cavalier; Régis P Radermecker; Nicolas Paquot; Gisèle Depas; Jean-Paul Chapelle; André J Scheen; Jean-Marie Krzesinski
Cystatin C or creatinine for detection of stage 3 chronic kidney disease in anorexia nervosa.
Nephron. Clinical practice 2008;110(3):c158-63.
2007: André J Scheen; J De Flines; Nicolas Paquot
[What about the controversy regarding rosiglitazone].
Revue médicale de Liège 2007;62(9):560-5.
2007: André J Scheen; Régis P Radermecker; JC Philips; Nicolas Paquot
[Incretin mimetics and incretin enhancers for the treatment of type 2 diabetes].
Revue médicale suisse 2007;3(122):1884, 1886-8.
2007: M Rorive; J De Flines; Nicolas Paquot; Arnaud De Roover; André J Scheen
[Recent advances in the management of obesity].
Revue médicale de Liège 2007;62(5-6):329-34.
2007: Nicolas Paquot; JC Philips; Régis P Radermecker; Pierre J Lefèbvre
[Recent advances in the management of diabetes mellitus].
Revue médicale de Liège 2007;62(5-6):317-23.
2007: André J Scheen; Régis P Radermecker; JC Philips; M Rorive; J De Flines; P Ernest; Nicolas Paquot
[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].
Revue médicale de Liège 2007;62 Spec No():40-6.
2006: Nicolas Paquot; André J Scheen
[Role of micronutrients in medicine].
Revue médicale de Liège 2006;61(5-6):464-70.
2006: A J Scheen; Nicolas Paquot
[Physiopathology of post-prandial hyperglycemia].
Journées annuelles de diabétologie de l'Hôtel-Dieu 2006;():47-65.
2005: André J Scheen; Régis P Radermecker; JC Philips; Nicolas Paquot
[Insulin detemir (Levemir)].
Revue médicale de Liège 2005;60(10):814-9.
2005: V Thielen; Régis P Radermecker; JC Philips; Nicolas Paquot; André J Scheen
[Hereditary hemochromatosis and diabetes mellitus: diagnostic approach and clinical evolution].
Revue médicale de Liège 2005;60(5-6):448-54.
2005: André J Scheen; Nicolas Paquot
[Insulin sensitizers].
Revue médicale de Liège 2005;60(5-6):409-13.
2005: Nicolas Paquot
[Diet and nutrition principles in type 2 diabetes].
Revue médicale de Liège 2005;60(5-6):391-4.
2005: Nicolas Paquot; L Tappy
[Adipocytokines: link between obesity, type 2 diabetes and atherosclerosis].
Revue médicale de Liège 2005;60(5-6):369-73.
2005: Arnaud De Roover; Olivier Detry; C Coimbra; C Bonvoisin; Marianne Beaujean; J M Krzesinski; Nicolas Paquot; A J Scheen; Pierre Honoré; Michel Meurisse
[Pancreas transplantation in the management of diabetes].
Revue médicale de Liège 2005;60(5-6):350-4.
2005: Nicolas Paquot; Jean Delwaide
Fatty liver in the intensive care unit.
Current opinion in clinical nutrition and metabolic care 2005;8(2):183-7.
2005: André J Scheen; Nicolas Paquot
[PPAR-gamma receptors, new therapeutic target in metabolic and cardiovascular diseases].
Revue médicale de Liège 2005;60(2):89-95.
2004: V Thielen; Nicolas Paquot; André J Scheen
[Hematochromatosis and diabetes].
Revue médicale de Liège 2004;59(1):29-31.
2003: Philippe Autier; Jean Creplet; Greet Vansant; Christian Brohet; Nicolas Paquot; Erik Muls; patrick mullie; André-Robert Grivegnée
The impact of reimbursement criteria on the appropriateness of 'statin' prescribing.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2003;10(6):456-62.
2003: E Lebas; Nicolas Paquot; André J Scheen
[Adiponectin: a new adipocytokine].
Revue médicale de Liège 2003;58(9):554-8.
2003: Régis P Radermecker; BJ Jandrain; Nicolas Paquot; JC Philips; E Contessi; M Lavigne; A M Rinaldi; André J Scheen
[Prevention of hypoglycemia in patients with type 1 diabetes].
Revue médicale de Liège 2003;58(6):361-8.
2003: Nicolas Paquot; André J Scheen
[Prevention of cardiovascular disease in type 2 diabetes].
Revue médicale de Liège 2003;58(5):271-4.
2003: André J Scheen; Nicolas Paquot
[Blood glucose control and prevention of microangiopathy and macroangiopathy in type 2 diabetes].
Revue médicale de Liège 2003;58(5):265-70.
2002: André J Scheen; MR Letiexhe; I Geronooz; Nicolas Paquot; BJ Jandrain
[Postprandial hyperglycemia. II. Pharmacological approaches].
Revue médicale de Liège 2002;57(4):196-201.
2002: André J Scheen; Nicolas Paquot; BJ Jandrain; Pierre J Lefèbvre
[Postprandial hyperglycemia. I. Physiopathology, clinical consequences and dietary management].
Revue médicale de Liège 2002;57(3):138-41.
2002: Nicolas Paquot; André J Scheen; Mirjam Dirlewanger; Pierre J Lefèbvre; Luc Tappy
Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
Obesity research 2002;10(3):129-34.
2002: André J Scheen; Nicolas Paquot; BJ Jandrain
[How I explore ... the risk of a patient developing type 2 diabetes].
Revue médicale de Liège 2002;57(2):113-5.
2001: André J Scheen; JC Philips; Françoise Luyckx; Nicolas Paquot; BJ Jandrain
[How I explore ... the different forms of sugar diabetes: clinical and biological differental diagnosis].
Revue médicale de Liège 2001;56(9):650-5.
2001: André J Scheen; Nicolas Paquot
[Beneficial effects of physical activity on cardiovascular risk factors].
Revue médicale de Liège 2001;56(4):239-43.
2001: Nicolas Paquot
[Sports nutrition].
Revue médicale de Liège 2001;56(4):200-3.
2000: Nicolas Paquot; Philippe Schneiter; André J Scheen; Pierre J Lefèbvre; L Tappy
Assessment of postprandial hepatic glycogen synthesis from uridine diphosphoglucose kinetics in obese and lean non-diabetic subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(10):1297-302.
2000: Nicolas Paquot; André J Scheen; Pierre J Lefèbvre
[GLycemic control in the diabetic patient. Recommendations after the DCCT and UKPDI studies].
Revue médicale de Liège 2000;55(5):372-5.
2000: Nicolas Paquot; M J Castillo; P J Lefèbvre; A J Scheen
No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients.
The Journal of clinical endocrinology and metabolism 2000;85(3):1316-9.
2000: Mirjam Dirlewanger; Philippe Schneiter; Nicolas Paquot; E Jequier; Valentine Rey; Luc Tappy
Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
Clinical nutrition (Edinburgh, Scotland) 2000;19(1):29-34.
1999: JF Surmely; Nicolas Paquot; Philippe Schneiter; E Jequier; E Temler; Luc Tappy
Non oxidative fructose disposal is not inhibited by lipids in humans.
Diabetes & metabolism 1999;25(3):233-40.
1999: AJ Scheen; Nicolas Paquot
[Type II diabetes: diagnostic approaches, glycemia objectives and therapeutic strategies].
Revue médicale de Liège 1999;54(8):659-66.
1999: AJ Scheen; Nicolas Paquot; Pierre J Lefèbvre
[Glucotoxicity and lipotoxicity, two implicated accomplices in the vicious circle of type 2 diabetes].
Revue médicale de Liège 1999;54(6):535-8.
1999: Nicolas Paquot
[Is it necessary to institute primary preventive treatment in women with hypercholesterolemia?].
Revue médicale de Liège 1999;54(4):240-3.
1999: JF Surmely; Philippe Schneiter; S Henry; Nicolas Paquot; E Jequier; Luc Tappy
Effects of glucagon in the control of endogenous glucose production in man.
Nutrition (Burbank, Los Angeles County, Calif.) 1999;15(4):267-73.
1999: A J Scheen; Nicolas Paquot; MR Letiexhe; Pierre J Lefèbvre
[Thiazolidinediones].
Journées annuelles de diabétologie de l'Hôtel-Dieu 1999;():213-29.
1998: Nicolas Paquot; D Roulin; Philippe Schneiter; J Ruiz; P Lefebvre; P Pahud; Luc Tappy
Effects of regular insulin or insulin LISPRO on glucose metabolism after an oral glucose load in patients with type 2 diabetes mellitus.
Diabetes & metabolism 1998;24(6):523-8.
1998: A J Scheen; Nicolas Paquot; K Triches; Françoise Luyckx; MR Letiexhe; P J Lefebvre
[Ultimate treatment of type 2 diabetes: intensive insulin therapy or bariatric surgery?].
Journées annuelles de diabétologie de l'Hôtel-Dieu 1998;():81-97.
1997: André J Scheen; Nicolas Paquot; Pierre J Lefèbvre
[How I investigate the new criteria for the diagnosis of diabetes mellitus].
Revue médicale de Liège 1997;52(9):606-9.
1997: Yves Beguin; V Grek; G Weber; Brieuc Sautois; Nicolas Paquot; M Pereira; A Scheen; P Lefèbvre; Georges Fillet
Acute functional iron deficiency in obese subjects during a very-low-energy all-protein diet.
The American journal of clinical nutrition 1997;66(1):75-9.
1997: JC Philips; MR Letiexhe; Nicolas Paquot; André J Scheen; Pierre J Lefèbvre
[How I investigate... a patient newly diagnosed with/or at risk of diabetes type 1].
Revue médicale de Liège 1997;52(5):363-6.
1997: F Bustin; S R Pestieau; Nicolas Paquot; André J Scheen; Pierre J Lefèbvre
[Energy expenditure in man].
Revue médicale de Liège 1997;52(2):101-4.
1997: Luc Tappy; P Tounian; Nicolas Paquot
Autoregulation of endogenous glucose production in man.
Biochemical Society transactions 1997;25(1):11-3.
1996: Nicolas Paquot
[Pharma-clinics. How I treat ... a Type 2 diabetic patient with diet].
Revue médicale de Liège 1996;51(8):497-9.
1996: Nicolas Paquot; Philippe Schneiter; E Jéquier; R Gaillard; P J Lefèbvre; A Scheen; L Tappy
Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjects.
Diabetologia 1996;39(5):580-6.
1996: P Lefebvre; Nicolas Paquot; A Scheen
[Role of the liver in carbohydrate homeostasis: a re-reading of the works of Claude Bernard].
Journées annuelles de diabétologie de l'Hôtel-Dieu 1996;():1-9.
1995: A J Scheen; Nicolas Paquot; MR Letiexhe; M J Castillo; Pierre J Lefebvre
[How should insulin secretion be evaluated in practice?].
Diabète & métabolisme 1995;21(6):458-64.
1995: Nicolas Paquot; Philippe Schneiter; M C Cayeux; René L Chiolero; E Temler; E Jequier; Luc Tappy
Effects of infused sodium lactate on glucose and energy metabolism in healthy humans.
Diabète & métabolisme 1995;21(5):345-52.
1995: A J Scheen; Nicolas Paquot; MR Letiexhe; G Paolisso; M J Castillo; Pierre J Lefèbvre
Glucose metabolism in obese subjects: lessons from OGTT, IVGTT and clamp studies.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1995;19 Suppl 3():S14-20.
1995: A J Scheen; MR Letiexhe; Nicolas Paquot; Pierre J Lefèbvre
[Clinical case of the month. Prolonged spontaneous remission of a typical type 1 diabetes].
Revue médicale de Liège 1995;50(9):363-4.
1995: Nicolas Paquot; Philippe Schneiter; Eric Jéquier; Luc Tappy
Effects of glucocorticoids and sympathomimetic agents on basal and insulin-stimulated glucose metabolism.
Clinical physiology (Oxford, England) 1995;15(3):231-40.
1995: Y Biessaux; Nicolas Paquot; A J Scheen; Pierre J Lefèbvre
[Clinical case of the month. Apropos of a case of ectopic ACTH secretion].
Revue médicale de Liège 1995;50(2):55-6.
1995: A J Scheen; Nicolas Paquot; MR Letiexhe; M J Castillo; Pierre J Lefebvre
[How to explore insulin sensitivity in man?].
Annales d'endocrinologie 1995;56(5):523-30.
1995: Luc Tappy; Nicolas Paquot; P Tounian; Philippe Schneiter; Eric Jéquier
Assessment of glucose metabolism in humans with the simultaneous use of indirect calorimetry and tracer techniques.
Clinical physiology (Oxford, England) 1995;15(1):1-12.
1994: A J Scheen; Nicolas Paquot; MR Letiexhe; M J Castillo; Pierre J Lefebvre
[How should insulin sensitivity be evaluated in practice?].
Diabète & métabolisme 1994;20(6):556-61.
1994: Luc Tappy; D Randin; P Vollenweider; L Vollenweider; Nicolas Paquot; Urs Scherrer; Philippe Schneiter; Pascal Nicod; Eric Jéquier
Mechanisms of dexamethasone-induced insulin resistance in healthy humans.
The Journal of clinical endocrinology and metabolism 1994;79(4):1063-9.
1994: A J Scheen; Nicolas Paquot; M J Castillo; Pierre J Lefèbvre
How to measure insulin action in vivo.
Diabetes/metabolism reviews 1994;10(2):151-88.
1994: Bernard Duysinx; A J Scheen; P L Gerard; MR Letiexhe; Nicolas Paquot; Pierre J Lefebvre
Measurement of insulin sensitivity by the minimal model method using a simplified intravenous glucose tolerance test: validity and reproducibility.
Diabète & métabolisme 1994;20(4):425-32.
1994: Bernard Duysinx; A J Scheen; Nicolas Paquot; C Daubresse; M Castillo; Pierre J Lefèbvre
[Type 2 insulin-dependent diabetes: patient characteristics and effects of insulin therapy].
Revue médicale de Liège 1994;49(6):305-23.
1988: Nicolas Paquot; A J Scheen; P Franchimont; Pierre J Lefebvre
The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man.
Diabète & métabolisme 1988;14(1):31-6.